News

Approximately 21 patient and consumer organizations (PCOs) participated in European Medicines Agency (EMEA) activities in 2007 and more than 92% of their representatives expressed satisfaction at the EMEA

The Phase II trial is an open-label, multi-center study of CR011-vcMMAE administered intravenously once every three weeks to patients with locally-advanced or metastatic breast cancer who have received

The company expects its Phase I/II clinical study for prevention or treatment of delayed graft function (DGF) in kidney transplant patients to begin in the second half of

The grant will help fund continuing experiments directed towards the development and commercialization of novel, automated, and reproducible methods for the extraction of clinically important protein biomarkers, subcellular

The protective effect of progesterone in treating brain injury has been firmly established but the inability to develop a product that can be used in the field by

The National Institute for Health and Clinical Excellence (NICE) has recommended adalimumab as a treatment option for adults with plaque psoriasis for whom anti-tumour necrosis factor treatment is

The potential annual sales by ANDAPharm with this product, including an earlier contract with a second pharmaceutical company, are between $7.5 million and $8 million. John Copanos, ANDAPharm’s

The product will include a heart disease pre-test risk calculator, a coronary disease reversal and prevention practice management program, a web-based, patient centric, disease reversal and life style

Kinrix (diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine], manufactured by GlaxoSmithKline, is said to be the latest combination vaccine. Clinical studies of Kinrix